Longevity Play TMRW Raises $7M Seed Round from Tidal, Signs Deal with TruDiagnostic – Capital Brief





Longevity Play TMRW Raises $7M Seed Round from Tidal, Signs Deal with TruDiagnostic – Capital Brief





















Skip to content

The longevity platform founded by former iflix CEO Mark Britt has closed its first round of venture capital, backed in large part by its own members.

Mark Britt, CEO of Tmrw.
Supplied.

Your cells have an age and it is not the same as your birthday. Solving that has become a booming industry.

While blood diagnostics have become the bread and butter of a thousand new health platforms, most will hand you a PDF with 30 data points and call it a day. TMRW executive director Mark Britt It is building about 1,700.

TMRW has raised approximately $7 million in seed funding to expand its clinical presence and refine the patient experience, moving beyond digital-only health tools to a proactive clinical environment.

The round was led by Tidal adventureswith the participation of the Melbourne fund Zed capital and a cohort of high-net-worth entrepreneurs and family offices, most of whom are active members of TMRW.













© 2026 Capital Brief Pty Ltd.


Latest Update